Extracorporeal membrane oxygenation in Jehovah's Witness patients: Case report, literature review, and summary of recommendations.

ECMO Jehovah’s Witness extracorporeal life support extracorporeal membrane oxygenation transfusion

Journal

Perfusion
ISSN: 1477-111X
Titre abrégé: Perfusion
Pays: England
ID NLM: 8700166

Informations de publication

Date de publication:
23 Sep 2021
Historique:
pubmed: 24 9 2021
medline: 24 9 2021
entrez: 23 9 2021
Statut: aheadofprint

Résumé

Extracorporeal Membrane Oxygenation (ECMO) is commonly associated with a high blood transfusion requirement. Jehovah's Witness patients present a particular challenge. The impossibility of transfusing blood cells and starting anticoagulation treatment are common contraindications for this supportive measure. Here we report the case of a Jehovah's Witness patient with refractory hypoxemia due to influenza A H1N1 pneumonia who required venovenous ECMO for 11 days. We describe the use of a bloodless approach to reduce the waste of blood, avoiding anticoagulation, and improving red blood cell production. We then summarize the current literature on the use of ECMO in Jehovah's Witness patients and, finally, we propose some recommendations for their management.

Identifiants

pubmed: 34554022
doi: 10.1177/02676591211047774
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2676591211047774

Auteurs

Abrahán Mera (A)

Intensive Care Medicine Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Shock, Organ Dysfunction, and Resuscitation Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.

Eduard Argudo (E)

Intensive Care Medicine Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Shock, Organ Dysfunction, and Resuscitation Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.
Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.

María Martínez-Martínez (M)

Intensive Care Medicine Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Shock, Organ Dysfunction, and Resuscitation Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.
Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.

Clara Palmada (C)

Intensive Care Medicine Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Shock, Organ Dysfunction, and Resuscitation Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.

Camilo Bonilla (C)

Intensive Care Medicine Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Shock, Organ Dysfunction, and Resuscitation Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.

Andrés Pacheco (A)

Intensive Care Medicine Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Shock, Organ Dysfunction, and Resuscitation Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.

Luis Chiscano (L)

Intensive Care Medicine Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Shock, Organ Dysfunction, and Resuscitation Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.

Gemma Marín (G)

Intensive Care Medicine Department, Vall d'Hebron University Hospital, Barcelona, Spain.

Beatriz Lozano (B)

Intensive Care Medicine Department, Vall d'Hebron University Hospital, Barcelona, Spain.

Elisabet Gallart (E)

Intensive Care Medicine Department, Vall d'Hebron University Hospital, Barcelona, Spain.

Jordi Riera (J)

Intensive Care Medicine Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Shock, Organ Dysfunction, and Resuscitation Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.
Centro de Investigación Biomédica en Red Enfermedades Respiratorias. Instituto de Salud Carlos III, Madrid, Spain.

Classifications MeSH